Classic Minerals ramps up high-grade gold hunt

|

Published 06-AUG-2018 13:00 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Classic Minerals (ASX:CLZ) has kicked off reverse circulation (RC) drilling at its Forrestania Gold Project in WA.

Following on from the encouraging results from its last programs at the Kat Gap, Lady Magdalene and Lady Lila prospects, CLZ will be targeting these areas again with 2000 metres of additional drilling.

The Forrestania Project contains an existing JORC (2012)-compliant Mineral Resource of 5.3 Mt at 1.39 g/t for 240,000 ounces of gold, with a recent scoping study suggesting both the technical and financial viability of the project.

CLZ sees great potential for the discovery of a substantial shallow high-grade gold deposit within the Kat Gap project area; the upcoming program will be testing for extensions of the high grade system.

Additional high-grade cross-cutting lodes will also be targeted at Lady Magdalene. This prospect is a large, modestly graded deposit which appears to host high-grade, cross-cutting gold lodes within existing drill lines that are 100-200 metres apart. The upcoming RC drilling program is designed to further delineate the east-west strike extent of the new high-grade quartz veins recently discovered here.

Further to that, CLZ will be testing Lady Lila extensions at depth and along strike.

Assay results are expected in early September.

Of course, as with all minerals exploration, success is not guaranteed — consider your own personal circumstances before investing, and seek professional financial advice.

Classic CEO, Dean Goodwin, said: “Following the outstanding results of our last drilling program, including multiple high-grade gold hits at Kat Gap and Lady Magdalene, we are very excited to be heading back to the FGP to undertake an aggressive follow up drill program.

“As you will see, this drill program is focused more so on our 100% Kat Gap project, which delivered outstanding results during the previous two drill campaigns, and is shaping up to become a prolific shallow high-grade gold deposit with so much remaining upside potential. We have only tested 140m of 3.5km of potential strike along this granite-greenstone contact and intersected a new zone of mineralisation in the granite.

“We are also very happy to be continuing the extensional drilling at Lady Magdalene and Lady Lila, which remain flagship assets in our FGP portfolio,” added Goodwin.

“Over the past 12 months, the company has been busy gaining a thorough understanding of the local geology and controls on mineralisation. All of the drill programs undertaken at FGP by Classic have yielded high grade gold hits. There is no doubt in my mind that this is a major gold camp containing significant undiscovered resources and we are on the right path to discover and delineate these ore bodies,” said Goodwin.

CLZ’s Forrestania tenure shown in red, including drill targets


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X